Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, March 2000, p. 226-232, Vol. 7, No. 2
Department of Clinical Studies, Central
Laboratory, The Royal Veterinary and Agricultural University,
Copenhagen, Denmark,1 and Section of
Leukocyte Biology, Department of Pediatrics, Baylor College of
Medicine, Houston, Texas 770302
Received 20 June 1999/Returned for modification 21 September
1999/Accepted 6 January 2000
In this report, we demonstrate that canine growth hormone (cGH) is
capable of priming canine polymorphonuclear neutrophil granulocytes
(PMN) in a manner resembling that of human PMN. The cGH influences
important functions that are involved in the process of recruitment of
PMN, i.e., shape change, chemotaxis, CD11b/CD18 expression, adhesion,
and subsequent transendothelial migration. Also, intracellular
O2
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of the Priming Effect by Pituitary
Canine Growth Hormone on Canine Polymorphonuclear Neutrophil
Granulocyte Function
production was evaluated. We investigated
the priming effect by incubating PMN with purified pituitary cGH at
various concentrations (10 to 800 µg/liter). The capacity for shape
change was significantly (P < 0.05) enhanced, whereas
the chemotactic response under agarose was significantly
(P < 0.05) reduced. The chemotactic migration in
Boyden chambers (10-µm-thick polycarbonate filter; lower surface count technique) was significantly (P < 0.05)
enhanced, presumably due to cGH-induced hyperadhesiveness to the lower
surface of the filters. The adhesion in albumin-coated microtiter
plates and adherence to canine pulmonary fibroblasts were significantly
(P < 0.05) increased, and the increased adhesion
resulted in a significant (P < 0.01) increase in
transendothelial migration using canine jugular vein endothelial cells.
The increase in adhesion was associated with a significant increase in
CD11b/CD18 expression. Furthermore, intracellular
O2
production was significantly enhanced in
response to both phorbol myristate acetate (P < 0.01)
and opsonized zymosan (P < 0.05). In the absence of a
PMN-stimulating agent, cGH did not influence the effector functions
investigated except for an increased expression of CD11b/CD18.
*
Corresponding author. Mailing address: Department of
Dermatological Research, Leo Pharmaceutical Products, Industriparken 55, 2750 Ballerup, Denmark. Phone: 45 44 92 38 00. Fax: 45 44 94 74 88. E-mail: thomas.petersen{at}leo-pharma.com.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |